Phenotypic Dermatology represents a new scientific paradigm that shifts dermatological diagnostics and therapy from morphological observation to cellular-phenotypic measurement.
Traditional dermatology, relying on visual description of primary and secondary lesions, cannot explain the true cellular mechanisms underlying visible skin changes.
The proposed approach interprets the skin as a dynamic system of interacting cell subpopulations, whose phenotypes determine the inflammatory, regulatory, and regenerative states of the tissue.
Using methods of flow cytometry and the author’s patented technology — the cytoimmunogram of the skin (CIGS) — it becomes possible to quantify the subpopulation composition of skin cells and to evaluate their phenotypic balance objectively.
This allows clinicians to replace descriptive diagnosis with measurable cellular criteria and to move toward precision and personalized dermatology.
Phenotypic Dermatology integrates cytology, immunology, systems biology, and conceptual analysis.
Its core assumption is that the phenotype of a cell subpopulation, rather than the morphology of a lesion, is the true diagnostic unit of the skin.
By identifying stable and dynamic phenotypic patterns, the theory explains the transition of the skin between inflammation, repair, and homeostasis.
The conceptual approach extends beyond morphology, introducing a phenotype-based language of diagnosis and a reproducible framework for evaluating disease dynamics.
The theoretical foundations are supported by a series of patented inventions and laboratory studies:
These technologies enabled reproducible phenotypic profiling of skin cell subpopulations and confirmed the link between specific phenotypes and clinical states such as atopic dermatitis, psoriasis, and chronic wounds.
The cytometric analysis of skin phenotypes provides:
Thus, Phenotypic Dermatology transforms a visual, symptom-based discipline into a measurable and predictive biomedical science.
Future research directions include:
Phenotypic Dermatology resolves the long-standing gap between visible symptoms and hidden cellular mechanisms.
It turns dermatology from the art of observation into the science of measurable causes, marking the beginning of a new era — where the state of the skin is defined not by what is seen, but by what can be quantified.
Author: Sergey V. Goltsov, MD, PhD